Dark Forest Capital Management LP Spring Works Therapeutics, Inc. Transaction History

Dark Forest Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$24.97 - $34.05 $222,482 - $303,385	8,910 New	8,910 $229,000
Q1 2022 May 13, 2022	SELL	$48.97 - $65.46 $12,438 - $16,626	-254 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$53.3 - $75.84 $13,538 - $19,263	254 New	254 $16,000
Q3 2021 Nov 12, 2021	SELL	$62.66 - $88.26 $237,669 - $334,770	-3,793 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$67.45 - $85.63 $255,837 - $324,794	3,793 New	3,793 $313,000

238

69.8M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.6B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.